Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Hologic Inc (HOLX)

Hologic Inc (HOLX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 19,453,480
  • Shares Outstanding, K 257,662
  • Annual Sales, $ 3,776 M
  • Annual Income, $ 1,115 M
  • 60-Month Beta 1.21
  • Price/Sales 5.09
  • Price/Cash Flow 13.51
  • Price/Book 5.97
Trade HOLX with:

Options Overview

Details
  • Implied Volatility 36.94%
  • Historical Volatility 46.05%
  • IV Percentile 66%
  • IV Rank 10.29%
  • IV High 175.34% on 03/16/20
  • IV Low 21.07% on 02/26/20
  • Put/Call Vol Ratio 0.29
  • Today's Volume 599
  • Volume Avg (30-Day) 2,737
  • Put/Call OI Ratio 0.47
  • Today's Open Interest 11,190
  • Open Int (30-Day) 16,027

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 11 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/21
See More
  • Average Estimate 2.61
  • Number of Estimates 8
  • High Estimate 2.66
  • Low Estimate 2.58
  • Prior Year 0.57
  • Growth Rate Est. (year over year) +357.89%

Price Performance

See More
Period Period Low Period High Performance
1-Month
71.08 +6.49%
on 01/27/21
85.00 -10.95%
on 02/16/21
unch (-0.01%)
since 01/22/21
3-Month
67.64 +11.91%
on 11/25/20
85.00 -10.95%
on 02/16/21
+8.02 (+11.84%)
since 11/24/20
52-Week
26.49 +185.75%
on 03/18/20
85.00 -10.95%
on 02/16/21
+24.30 (+47.27%)
since 02/24/20

Most Recent Stories

More News
Masimo (MASI) Earnings and Revenues Beat Estimates in Q4

Masimo (MASI) continues to gain from its key Product segment, which witnessed solid growth in Q4.

ANGO : 20.45 (+1.49%)
HOLX : 76.29 (+1.05%)
MASI : 248.73 (+0.21%)
ABT : 122.20 (+1.16%)
Here's Why You Should Retain Avanos Medical (AVNS) Stock Now

Investor confidence is high in Avanos Medical (AVNS) stock, courtesy of its solid prospects.

HOLX : 76.29 (+1.05%)
ABT : 122.20 (+1.16%)
ALGN : 572.31 (+0.79%)
AVNS : 46.30 (+4.12%)
Myriad Genetics (MYGN) Beats on Q2 Revenues, Earnings in Line

Myriad Genetics' (MYGN) sales in majority of the operating segments improved in the quarter despite pandemic-led business challenges.

HOLX : 76.29 (+1.05%)
MYGN : 30.24 (+4.17%)
ABT : 122.20 (+1.16%)
IDXX : 529.18 (+0.75%)
Insulet (PODD) Q4 Earnings Fall Shy of Estimates, Revenues Beat

Insulet's (PODD) Q4 revenues were significantly boosted by the robust adoption of Omnipod DASH and a growing customer base.

HOLX : 76.29 (+1.05%)
ABT : 122.20 (+1.16%)
IDXX : 529.18 (+0.75%)
PODD : 269.00 (+3.17%)
Fresenius Medical (FMS) Q4 Earnings Beat, Revenues Miss

Fresenius Medical's (FMS) fourth-quarter earnings benefit from strength in Health Care Products segment, and performance across EMEA and Asia Pacific.

ANGO : 20.45 (+1.49%)
HOLX : 76.29 (+1.05%)
FMS : 35.29 (+0.40%)
ABT : 122.20 (+1.16%)
Medtronic's (MDT) Q3 Earnings Beat Estimates, Margins Fall

Medtronic (MDT) procedure volumes hurt by resurgence of COVID-19 cases despite increased demand for related diagnostics and therapies.

MDT : 119.03 (+0.87%)
ANGO : 20.45 (+1.49%)
HOLX : 76.29 (+1.05%)
ABT : 122.20 (+1.16%)
Integer Holdings (ITGR) Gains 2.4% Post Q4 Earnings Beat

Integer Holdings' (ITGR) fourth-quarter results reflect weak segmental performance.

ANGO : 20.45 (+1.49%)
HOLX : 76.29 (+1.05%)
ABT : 122.20 (+1.16%)
ITGR : 86.41 (+2.92%)
Pacific Biosciences' (PACB) Sequel II Gets Deployed by LabCorp

Pacific Biosciences' (PACB) Sequel II HiFi sequencing gets utilized by LabCorp to detect SARS-COV-2 variants in the United States.

ANGO : 20.45 (+1.49%)
HOLX : 76.29 (+1.05%)
LH : 243.21 (-1.59%)
PACB : 38.06 (+2.53%)
BD (BDX), Scanwell Health Collaborate on At-Home Coronavirus Test

BD (BDX) plans to develop a lateral flow antigen test and pair it with the Scanwell Health mobile app via the latest partnership.

BDX : 245.61 (-0.84%)
HOLX : 76.29 (+1.05%)
ABT : 122.20 (+1.16%)
IDXX : 529.18 (+0.75%)
Respiratory Syntactical Virus (RSV) Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast 2020 to 2027

The report for Respiratory Syntactical Virus (RSV) offers an assiduous analysis of contemporary market trends, driving factors, consumer behavior, key player strategies, product usage and brand positioning....

ABT : 122.20 (+1.16%)
ABBV : 108.87 (+2.45%)
AZN : 50.21 (+1.83%)
GILD : 63.72 (+0.06%)
GSK : 34.62 (+0.70%)
HOLX : 76.29 (+1.05%)
LMNX : 30.11 (+6.89%)
MVRBF : 1.0000 (+3.09%)
MRK : 75.03 (+0.66%)
VRX.TO : 30.80 (-3.33%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Hologic, Inc. is a leading developer, manufacturer and supplier of premium diagnostic products, medical imaging systems and surgical products. The Company's core business units focus on diagnostics, breast health, GYN surgical, and skeletal health. With a unified suite of technologies and a robust research...

See More

Key Turning Points

3rd Resistance Point 80.02
2nd Resistance Point 78.25
1st Resistance Point 76.87
Last Price 76.29
1st Support Level 73.73
2nd Support Level 71.96
3rd Support Level 70.58

See More

52-Week High 85.00
Last Price 76.29
Fibonacci 61.8% 62.65
Fibonacci 50% 55.74
Fibonacci 38.2% 48.84
52-Week Low 26.49

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar